CBWTF: AI 评分 54/100 — AI 分析 (4月 2026)

Auxly Cannabis Group Inc. is a Canadian consumer packaged goods company focused on the cannabis market. They develop, manufacture, and distribute a range of cannabis products for both wellness and recreational use.

Key Facts: AI Score: 54/100 Sector: Healthcare

公司概况

概要：

Auxly Cannabis Group Inc. is a Canadian consumer-packaged goods company in the cannabis market, offering a diverse portfolio of cannabis products, including vapes, dried flower, concentrates, edibles, and topicals under brands like KOLAB PROJECT and Back Forty. They focus on recreational and wellness consumers in Canada.

CBWTF是做什么的？

Auxly Cannabis Group Inc., established in 1987 and formerly known as Cannabis Wheaton Income Corp. until June 2018, is a Canadian consumer packaged goods company operating within the cannabis market. Headquartered in Toronto, the company focuses on the development, manufacturing, and distribution of a diverse range of cannabis products targeted at both wellness and recreational consumers. Auxly's product portfolio includes various forms such as vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. These products are marketed under several brands, including KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. Auxly's business model centers around creating and distributing branded cannabis products to meet the evolving demands of the Canadian market. The company aims to establish a strong presence in the cannabis industry through product innovation, brand development, and strategic partnerships. With 388 employees, Auxly is committed to delivering high-quality cannabis products and experiences to its consumers.

CBWTF的投资论点是什么？

Auxly Cannabis Group Inc. presents a compelling investment thesis based on its established presence in the Canadian cannabis market and its focus on consumer-packaged goods. With a market capitalization of $0.12 billion and a price-to-earnings ratio of 4.00, the company demonstrates potential value. A gross margin of 59.5% and a profit margin of 31.1% indicate operational efficiency. Growth catalysts include expansion of its product lines and increased market penetration within Canada. Key risks include regulatory changes and competition from other cannabis producers. Investors should monitor the company's ability to maintain profitability and expand its market share in the evolving cannabis landscape.

CBWTF在哪个行业运营？

Auxly Cannabis Group Inc. operates within the rapidly evolving Canadian cannabis industry, which has seen significant growth since legalization. The market is characterized by increasing competition, evolving consumer preferences, and ongoing regulatory changes. Auxly competes with other cannabis producers and consumer packaged goods companies, including AAWH (AWH Corp), BKUH (Akanda Corp), BXPHF (Flora Growth Corp), HLTRF (Halo Collective Inc), and JUSHF (Jushi Holdings Inc). The company's success depends on its ability to differentiate its products, build strong brands, and navigate the complex regulatory landscape.

Drug Manufacturers - Specialty & Generic

Healthcare

CBWTF有哪些增长机遇？

Expansion of Product Lines: Auxly has the opportunity to expand its product lines to include new and innovative cannabis products, such as edibles, beverages, and wellness products. The market for cannabis-infused products is growing rapidly, driven by increasing consumer demand for alternative consumption methods. By introducing new products, Auxly can attract new customers and increase its market share. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously innovates and introduces new products to the market.
Increased Market Penetration: Auxly can increase its market penetration by expanding its distribution network and reaching new customers in Canada. The Canadian cannabis market is still relatively young, and there is significant potential for growth as more consumers become aware of and comfortable with cannabis products. By expanding its distribution network and increasing its marketing efforts, Auxly can reach new customers and increase its sales. The timeline for this growth opportunity is ongoing, as Auxly continues to expand its reach across Canada.
Strategic Partnerships: Auxly can form strategic partnerships with other companies in the cannabis industry, such as retailers, distributors, and technology providers. These partnerships can help Auxly to expand its reach, improve its efficiency, and access new technologies. For example, Auxly could partner with a retailer to open new stores or with a technology provider to develop new cannabis products. The timeline for this growth opportunity is ongoing, as Auxly continuously seeks out new partnerships to enhance its business.
International Expansion: Auxly can expand its operations into international markets, such as Europe and Latin America. The global cannabis market is growing rapidly, and there is significant potential for Auxly to expand its reach and increase its sales by entering new markets. However, international expansion also carries risks, such as regulatory uncertainty and competition from local players. The timeline for this growth opportunity is medium to long term, as Auxly carefully evaluates potential international markets and develops its expansion strategy.
Focus on High-Margin Products: Auxly can focus on developing and marketing high-margin cannabis products, such as premium flower, concentrates, and edibles. These products typically command higher prices and generate greater profits than lower-margin products, such as commodity flower. By focusing on high-margin products, Auxly can improve its profitability and increase its shareholder value. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously evaluates its product portfolio and adjusts its strategy to focus on high-margin products.

Market capitalization of $0.12 billion indicates the company's current valuation in the market.
P/E ratio of 4.00 suggests the stock may be undervalued compared to its earnings.
Profit margin of 31.1% demonstrates strong profitability in the cannabis industry.
Gross margin of 59.5% reflects efficient cost management in product manufacturing and sales.
Beta of 1.20 indicates the stock is more volatile than the overall market.

CBWTF提供哪些产品和服务？

Develops and manufactures cannabis products.
Distributes cannabis products across Canada.
Offers vape cartridges, dried flower, and concentrates.
Produces cannabis-infused chocolates and soft chews.
Sells oil drops, capsules, and topicals.
Markets products under the KOLAB PROJECT brand.
Markets products under the Dosecann brand.
Markets products under the BACK FORTY brand.

CBWTF如何赚钱？

Develops and manufactures cannabis products in-house and through partnerships.
Distributes products through established retail channels across Canada.
Focuses on branded cannabis products to build customer loyalty and market share.

Recreational cannabis consumers in Canada.
Wellness-focused consumers seeking cannabis-based products.
Adults of legal age in provinces and territories where cannabis is legal.

Established brands such as KOLAB PROJECT and BACK FORTY.
Strong distribution network across Canada.
Focus on product innovation and development.

什么因素可能推动CBWTF股价上涨？

Ongoing: Expansion of product lines to include new cannabis-infused products.
Ongoing: Increased market penetration through expanded distribution networks.
Upcoming: Potential regulatory changes in the Canadian cannabis market.
Upcoming: Strategic partnerships with retailers and distributors.
Ongoing: Focus on developing and marketing high-margin cannabis products.

CBWTF的主要风险是什么？

Potential: Increasing competition from other cannabis companies in Canada.
Ongoing: Changes in cannabis regulations that could impact operations.
Potential: Fluctuations in cannabis prices affecting profitability.
Ongoing: Negative consumer perception of cannabis products.
Potential: Difficulty in securing financing for expansion plans.

CBWTF的核心优势是什么？

Established brands in the Canadian market.
Diverse product portfolio.
Strong distribution network.
Experienced management team.

CBWTF的劣势是什么？

Reliance on the Canadian market.
Limited international presence.
Exposure to regulatory changes.
Competition from larger cannabis companies.

CBWTF有哪些机遇？

Expansion into new product categories.
Increased market penetration in Canada.
Strategic partnerships with other companies.
International expansion into new markets.

CBWTF面临哪些威胁？

Increasing competition from other cannabis companies.
Changes in cannabis regulations.
Fluctuations in cannabis prices.
Negative consumer perception of cannabis.

CBWTF的竞争对手是谁？

AWH Corp — Multi-state operator in the US cannabis market. — (AAWH)
Akanda Corp — Focuses on medical cannabis in international markets. — (BKUH)
Flora Growth Corp — Vertically integrated cannabis company with a focus on Latin America. — (BXPHF)
Halo Collective Inc — Cannabis company with operations in the US and Canada. — (HLTRF)
Jushi Holdings Inc — Multi-state operator with a focus on high-growth markets in the US. — (JUSHF)

Key Metrics

MoonshotScore: 54/100

Company Profile

CEO: Hugo Alves
Headquarters: Toronto, CA
Employees: 388
Founded: 2017

AI Insight

AI analysis pending for CBWTF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Auxly Cannabis Group Inc. do?

Auxly Cannabis Group Inc. is a consumer packaged goods company in the Canadian cannabis market. They focus on developing, manufacturing, and distributing a variety of cannabis products for both recreational and wellness consumers. Their product range includes vape cartridges, dried flower, concentrates, edibles like chocolates and soft chews, oil drops, capsules, and topicals, all marketed under brands such as KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company aims to provide diverse cannabis experiences to meet evolving consumer preferences in Canada.

What do analysts say about CBWTF stock?

Analyst coverage of Auxly Cannabis Group Inc. (CBWTF) is limited, reflecting its OTC listing and smaller market capitalization. Key valuation metrics include its P/E ratio of 4.00, which may suggest undervaluation, and its gross margin of 59.5%, indicating efficient operations. Growth considerations center on its ability to expand its market share in Canada, introduce new products, and manage regulatory risks. Investors should conduct their own due diligence and consider their risk tolerance before investing.

What are the main risks for CBWTF?

The main risks for Auxly Cannabis Group Inc. include increasing competition in the Canadian cannabis market, regulatory changes that could impact its operations, and fluctuations in cannabis prices that could affect its profitability. As an OTC-listed company, CBWTF also faces risks related to liquidity and information disclosure. Negative consumer perception of cannabis products and difficulty in securing financing for expansion plans are additional challenges. Investors should carefully consider these risks before investing in CBWTF.

What are the key growth opportunities for CBWTF in healthcare?

Auxly Cannabis Group Inc. can capitalize on growth opportunities within the healthcare sector by expanding its product lines to include cannabis-based wellness and therapeutic products. This includes developing formulations targeting specific health conditions, such as pain management, anxiety, and sleep disorders. Strategic partnerships with healthcare providers and research institutions can also facilitate the development and validation of these products. Additionally, Auxly can explore opportunities in the medical cannabis market, which often commands higher margins and greater regulatory support.

How does Auxly Cannabis Group Inc. navigate regulatory approval processes?

As a cannabis company operating in Canada, Auxly Cannabis Group Inc. navigates regulatory approval processes by adhering to the regulations set forth by Health Canada. This includes obtaining licenses for cultivation, processing, and distribution, as well as complying with strict quality control standards. Auxly also engages with regulatory bodies to stay informed about upcoming changes and to advocate for policies that support the growth of the cannabis industry. Furthermore, the company invests in research and development to ensure its products meet regulatory requirements and consumer safety standards.